On November 23, 2022, in a notice, the Office of the U.S. Trade Representative (USTR) announced the extensions of 81 Section 301 medical product exclusions related to the COVID-19 pandemic.
The exclusions were set to expire on November 30, 2022, but they will now be valid through February 28, 2023.
The notice can be found here:
https://ustr.gov/sites/default/files/2022-11/COVID%20extensions%20FRN.pdf